Last month, China's Chery Automobile unveiled an all-solid-state battery it says can deliver a driving range exceeding 1,500 kilometers, positioning the technology as a central pillar of its next ...
Chimeric antigen receptor (CAR) T-cell therapy is an impactful treatment for blood cancers, such as leukemia and lymphoma. However, the immunotherapy has struggled against solid tumors, as tumor cells ...
The race to bring solid-state EV batteries to market is well underway, but there is an intermediate stage before we reach that technological benchmark: the semi-solid-state battery. Chinese automaker ...
Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and lymphoma. But the immunotherapy has struggled against solid tumors for two ...
Solid-state batteries could solve the two biggest barriers to EV adoption: anxiety about range and long charging times. Solid Power is taking a practical approach by designing solid-state batteries ...
Canada recently signed a new trade agreement with China, reducing tariffs on up to 49,000 Chinese electric vehicles (EVs) each year. By 2030, half of these imported vehicles are anticipated to be ...
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox. Feed your ...
UCLA scientists have developed a next-generation CAR-T cell therapy that can overcome the immunosuppressive tumor microenvironment, a protective shield that tumors use to weaken immune cells, block ...
CAR T cell therapy has revolutionized the treatment of many blood cancers, but has shown little success against solid tumors, which account for more than 85% of all cancers. Columbia University ...
Though CAR T cells have been effective against certain blood cancers, they have not been for solid tumors. Now, a new form of highly sensitive CAR T cells aims to overcome one of the biggest barriers ...
A new, highly sensitive cell therapy was able to wipe out three different kinds of solid tumors in mice, an important advance in an area where CAR-T cells have long struggled. But significant ...